Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

BACKGROUND: The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine serotype invasive pneumococcal disease among vaccine-eli...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Lancet Glob Health
Κύριοι συγγραφείς: Bar-Zeev, Naor, Swarthout, Todd D, Everett, Dean B, Alaerts, Maaike, Msefula, Jacquline, Brown, Comfort, Bilima, Sithembile, Mallewa, Jane, King, Carina, von Gottberg, Anne, Verani, Jennifer R, Whitney, Cynthia G, Mwansambo, Charles, Gordon, Stephen B, Cunliffe, Nigel A, French, Neil, Heyderman, Robert S
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Elsevier Ltd 2021
Θέματα:
Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8220129/
https://ncbi.nlm.nih.gov/pubmed/34143997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2214-109X(21)00165-0
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια